Zhao-Liang SHAN

Zhao-Liang SHAN


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Molecular Biology Reports
Verified
Journal Article
Open access
PDF file
NZNana Zhu
Nana Zhu
TLTianlun Li
Tianlun Li
YBYili Bai
Yili Bai
JSJiao Sun
Jiao Sun
JGJianping Guo
Jianping Guo
ZSZhao-Liang SHAN
Zhao-Liang SHAN
Background: Atrial Fibrillation (AF), a prevalent arrhythmic condition, is intricately associated with atrial fibrosis, a major pathological contributor. Central to the development of atrial fibrosis is myocardial inflammation. This study focuses on Atrial Natriuretic Peptide (ANP) and its role in mitigating atrial fibrosis, aiming to elucidate the specific mechanisms by which ANP exerts its effects, with an emphasis on fibroblast dynamics. Methods and results: The study involved forty Sprague-Dawley rats, divided into four groups: control, Angiotensin II (Ang II), Ang II + ANP, and ANP only. The administration of 1 µg/kg/min Ang II was given to Ang II and Ang II + ANP groups, while both Ang II + ANP and ANP groups received 0.1 µg/kg/min ANP intravenously for a duration of 14 days. Cardiac fibroblasts were used for in vitro validation of the proposed mechanisms. The study observed that rats in the Ang II and Ang II + ANP groups showed an increase in blood pressure and a decrease in body weight, more pronounced in the Ang II group. Diastolic dysfunction, a characteristic of the Ang II group, was alleviated by ANP. Additionally, ANP significantly reduced Ang II-induced atrial fibrosis, myofibroblast proliferation, collagen overexpression, macrophage infiltration, and the elevated expression of Interleukin 6 (IL-6) and Tenascin-C (TN-C). Transcriptomic sequencing indicated enhanced PI3K/Akt signaling in the Ang II group. Furthermore, in vitro studies showed that ANP, along with the PI3K inhibitor LY294002, effectively reduced PI3K/Akt pathway activation and the expression of TN-C, collagen-I, and collagen-III, which were induced by Ang II. Conclusions: The study demonstrates ANP’s potential in inhibiting myocardial inflammation and reducing atrial fibrosis. Notably, ANP’s effect in countering atrial fibrosis seems to be mediated through the suppression of the Ang II-induced PI3K/Akt-Tenascin-C signaling pathway. These insights enhance our understanding of AF pathogenesis and position ANP as a potential therapeutic agent for treating atrial fibrosis.

7 September 2023 in Molecular Biology Reports
Verified
Journal Article
Open access
PDF file
QZQing Zhao
Qing Zhao
WYWentao Yang
Wentao Yang
XLXiangdong Li
Xiangdong Li
HYHongtao Yuan
Hongtao Yuan
JGJianping Guo
Jianping Guo
ZSZhao-Liang SHAN
Zhao-Liang SHAN
Background: Atrial fibrosis has been recognized as a typical pathological change in atrial fibrillation. Although present evidence suggests that microRNA-499-5p (miR-499-5p) plays an important role in the development of atrial fibrosis, the specific mechanism is not fully understood. Therefore, this study attempted to assess the influence of miR-499-5p on atrial fibroblasts and explore the potential molecular mechanism. Methods: Atrial fibroblasts from sprague dawley rat were respectively transfected with miR-499-5p mimic, miR-499-5p negative control and miR-499-5p inhibitor, atrial fibroblasts without any treatment were also established. Cell counting kit-8 assay and transwell assay were used to detect the proliferation and migration of atrial fibroblasts in each group. Expressions of miR-499-5p, TGF-β1, smad2, α-SMA, collagen-I and TGFβ-R1 in mRNA and protein level were subsequently detected via quantitative real-time polymerase chain reaction and western blot. Furthermore, the prediction of the binding sites of miR-499-5p and TGFβ-R1 was performed via the bioinformatics online software TargetScan and verified by dual luciferase reporter. Results: By utilizing miR-499-5p-transfected atrial fibroblasts model, expression of miR-499-5p in the miR-499-5p mimic group was upregulated, while it was downregulated in the miR-499-5p inhibitor group. Upregulated miR-499-5p expression led to a significant decrease in the proliferative and migratory ability of cultured atrial fibroblasts, while downregulated miR-499-5p expression led to a significant increase in the proliferative and migratory ability of cultured atrial fibroblasts. Additionally, upregulated miR-499-5p expression made a significant rise in TGF-β1-induced mRNA and protein expression of TGF-β1, TGFβ-R1, smad2, α-SMA and collagen-I in atrial fibroblasts. Furthermore, results from the dual luciferase reporter conformed that miR-499-5p may repress TGFβ-R1 by binding the 3′UTR of TGFβ-R1 directly. Conclusions: miR-499-5p is able to inhibit the activation of transforming growth factor β-induced Smad2 signaling and eventually suppressed the proliferation, migration and invasion of atrial fibroblasts and collagen synthesis by targeting TGFβ-R1.

23 February 2023 in Advances in Interventional Cardiology
Verified
Journal Article
Open access
QZQing Zhao
Qing Zhao
WYWentao Yang
Wentao Yang
XLXiangdong Li
Xiangdong Li
MYMinghui Yao
Minghui Yao
JGJianping Guo
Jianping Guo
ZSZhao-Liang SHAN
Zhao-Liang SHAN
Introduction: N-terminal pro-B-type natriuretic peptide (NT-proBNP) has been demonstrated as a valuable risk marker for mortality and morbidity of cardiovascular disease. Recurrence after atrial fibrillation (AF) radiofrequency catheter ablation remains common. Aim: We investigated the...

3 May 2024 in Gene
Verified
Journal Article
Closed access
TLTian-Lun Li
Tian-Lun Li
NZNa-Na Zhu
Na-Na Zhu
ZYZhao Yin
Zhao Yin
JSJiao Sun
Jiao Sun
JGJian-Pin Guo
Jian-Pin Guo
ZSZhao-Liang SHAN
Zhao-Liang SHAN

26 August 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
ZYZhao Yin
Zhao Yin
XNXiaohua Nie
Xiaohua Nie
TLTianlun Li
Tianlun Li
BZBei Zhao
Bei Zhao
SWShouli Wang
Shouli Wang
ZSZhao-Liang SHAN
Zhao-Liang SHAN
Introduction: It has been reported Gas6/AXL pathway participates in several diseases. However, due of the lack of specific antibody, the significance and change circulatory Gas6/AXL complex in related diseases remain unclear.Methods: The mice were immunized with human AXL protein which were expressed by L cells to obtain monoclonal antibodies (mAbs). The flow cytometry was used to monoclonal antibodies screening and binding region mapping. To prepare an AXL-Gas6 specific mAb coated ELISA plate, and test the level of AXL-Gas6 complex in human blood.Results and discussion: We successfully obtained an AXL monoclonal antibody only binding to Gas6/AXL complex. Using the antibody, we firstly found that AXL expressed on human pDCs had bind to Gas6. Not only applicated in flow cytometry, this novel antibody could also be used as capture antibody in ELISA. Depend on this antibody, we firstly discovered that sAXL Gas6 complex was significantly increased in patients with AMI. Compared to AXL detected by commercial kit, AXL-Gas6 complex we measured emerged as a more sensitive biomarker and risk factor for patients with ST-segment elevation myocardial infarction.

20 April 2024 in Molecular Biology Reports
Verified
Journal Article
Open access
PDF file
QZQing Zhao
Qing Zhao
WYWentao Yang
Wentao Yang
XLXiangdong Li
Xiangdong Li
HYHongtao Yuan
Hongtao Yuan
JGJianping Guo
Jianping Guo
ZSZhao-Liang SHAN
Zhao-Liang SHAN